Group 6 Copy 443
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do lichens withstand desiccation?

    Lichens, symbioses between fungi and algae, survive levels of desiccation lethal to most organisms. We recently...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Can we increase human safety by understanding the language of bears?

    Fear of bears has gripped humans for centuries but no scientific effort has sought to understand how to...

    Backer Badge Funded

    A biology project funded by 47 people